Literature DB >> 8407699

Helicobacter pylori infection.

A T Axon1.   

Abstract

The discovery of Helicobacter pylori is arguably the most significant advance made in gastroduodenal pathology this century. It is the most important cause of chronic gastritis, and almost certainly the major aetiological factor responsible for duodenal ulcer and probably for gastric ulcer as well. Evidence is accumulating which suggests that it may play an important role in the pathogenesis of gastric cancer. H. pylori is thought to be transmitted by the faecal-oral route or possibly oral-oral route, with iatrogenic transmission also reported. The prevalence of H. pylori infection increases with age, is commonest in developing countries, in certain ethnic minorities and those in lower socio-economic and educational groups. The organism can be eradicated using combinations of antibiotics; when treatment is successful inflammatory changes resolve, duodenal ulcers heal and do not subsequently recur.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407699     DOI: 10.1093/jac/32.suppl_a.61

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Helicobacter pylori and antibiotic resistance.

Authors:  Francis Megraud
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

2.  Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.

Authors:  A M Craig; P Davey; M Malek; F Murray
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

3.  Recognition of glycoconjugates by Helicobacter pylori: an apparently high-affinity binding of human polyglycosylceramides, a second sialic acid-based specificity.

Authors:  H Miller-Podraza; M A Milh; J Bergström; K A Karlsson
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

Review 4.  Helicobacter pylori infection.

Authors:  Grigorios I Leontiadis; Paul Moayyedi; Alexander Charles Ford
Journal:  BMJ Clin Evid       Date:  2009-10-01

5.  Helicobacter pylori in gastroduodenal diseases.

Authors:  Oladejo O Lawal; Olorunda Rotimi; Iruka Okeke
Journal:  J Natl Med Assoc       Date:  2007-01       Impact factor: 1.798

Review 6.  Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.

Authors:  B C Delaney
Journal:  Br J Gen Pract       Date:  1995-09       Impact factor: 5.386

7.  Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Helicobacter pylori eradication: gastric cancer prevention.

Authors:  Grigorios I Leontiadis; Alexander Charles Ford
Journal:  BMJ Clin Evid       Date:  2015-12-01

9.  Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media.

Authors:  P E Coudron; C W Stratton
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

10.  Transportation of Helicobacter pylori cultures by optimal systems.

Authors:  H X Xia; C T Keane; J Chen; J Zhang; E J Walsh; A P Moran; J S Hua; F Megraud; C A O'Morain
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.